iBio, Inc.
iBio, Inc. (IBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IBIO · as of Jun 8, 2026
Key Statistics
Explore iBio, Inc. Data
ibio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The IBIO analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +189.02% upside from the current price of $1.73.
Competitors & Peers
ibio competitorsIBIO
ANTX
BOLD
CVKD
INTS
ITRMStock Performance
Full HistoryAbout iBio, Inc.
iBio, Inc. a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two …
what is ibio, inc. · ibio stock overview · ibio, inc. company profile · who is ibio, inc. ceo · ibio NASDAQ · ibio, inc. headquarters · ibio, inc. business segments
About Stock Overview & Key Data
iBio, Inc. (IBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 19, 2008. As of the latest trading session, IBIO stock price is $1.73, with a market capitalization of $27.3M. The stock has returned +90.11% over the past 12 months and -10.36% year-to-date.
According to 4 Wall Street analysts, the consensus rating for iBio, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, iBio, Inc. reported revenue of $400000.00 and net income of -$18.4M. For detailed data — including iBio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, iBio, Inc. (IBIO) stock price is $1.73. The stock is traded on NASDAQ under the ticker symbol IBIO. The 52-week range is $0.56 – $3.82.